Circulating Levels of PF4/CXCL4 in Patients With BCR: :ABL1 ‐Negative Myeloproliferative Neoplasms: A New Potential Prognostic Factor for Disease Progression

Documenti analoghi

• Treatment‐free remission as a new goal in the management of chronic myeloid leukemia: Clinical and biological aspects
  di: Daniele Cattaneo, et al.
  Pubblicazione: (2024)
• Chinese Patients With BCR::ABL1‐Negative Myeloproliferative Neoplasms: Immunophenotype of Myeloid Monocytes
  di: Fengting Liang, et al.
  Pubblicazione: (2025)
• Role of Flow Cytometric Enumeration of Circulating hMICL ( CD371 ) Positive Leukemic Stem Cells in Diagnosis and Prognostication of BCR :: ABL1 ‐Negative Myeloproliferative Neoplasms
  di: Gurleen Oberoi, et al.
  Pubblicazione: (2026)
• High Frequency of Germline ATM Variants in Familial Philadelphia‐Negative Myeloproliferative Neoplasms
  di: Francesco Ramundo, et al.
  Pubblicazione: (2026)
• BCR‐ABL testing in the evaluation of neutrophilia
  di: Caleb J. Smith, et al.
  Pubblicazione: (2024)